Lava Therapeutics Nv Stock Current Ratio
| LVTX Stock | USD 1.55 0.06 3.73% |
LAVA Therapeutics NV fundamentals help investors to digest information that contributes to LAVA Therapeutics' financial success or failures. It also enables traders to predict the movement of LAVA Stock. The fundamental analysis module provides a way to measure LAVA Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LAVA Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 6.62 | 8.27 |
LAVA | Current Ratio |
LAVA Therapeutics NV Company Current Ratio Analysis
LAVA Therapeutics' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current LAVA Therapeutics Current Ratio | 6.74 X |
Most of LAVA Therapeutics' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LAVA Therapeutics NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
LAVA Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for LAVA Therapeutics is extremely important. It helps to project a fair market value of LAVA Stock properly, considering its historical fundamentals such as Current Ratio. Since LAVA Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LAVA Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LAVA Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
LAVA Current Ratio Historical Pattern
Today, most investors in LAVA Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LAVA Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of LAVA Therapeutics current ratio as a starting point in their analysis.
LAVA Therapeutics Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
LAVA Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, LAVA Therapeutics NV has a Current Ratio of 6.74 times. This is 131.62% higher than that of the Biotechnology sector and 3.71% lower than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
LAVA Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LAVA Therapeutics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LAVA Therapeutics could also be used in its relative valuation, which is a method of valuing LAVA Therapeutics by comparing valuation metrics of similar companies.LAVA Therapeutics is currently under evaluation in current ratio category among its peers.
LAVA Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.16 | ||||
| Operating Margin | (3.71) % | ||||
| Current Valuation | (38.3 M) | ||||
| Shares Outstanding | 26.3 M | ||||
| Shares Owned By Insiders | 28.72 % | ||||
| Shares Owned By Institutions | 31.88 % | ||||
| Number Of Shares Shorted | 19.11 K | ||||
| Price To Earning | 0.54 X | ||||
| Price To Book | 0.99 X | ||||
| Price To Sales | 5.72 X | ||||
| Revenue | 6.77 M | ||||
| Gross Profit | (20.71 M) | ||||
| EBITDA | (40.42 M) | ||||
| Net Income | (41.7 M) | ||||
| Cash And Equivalents | 110.71 M | ||||
| Cash Per Share | 4.29 X | ||||
| Total Debt | 6.31 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 6.74 X | ||||
| Book Value Per Share | 1.63 X | ||||
| Cash Flow From Operations | (38.97 M) | ||||
| Short Ratio | 0.34 X | ||||
| Earnings Per Share | (0.89) X | ||||
| Target Price | 6.64 | ||||
| Number Of Employees | 37 | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 42.34 M | ||||
| Total Asset | 101.71 M | ||||
| Retained Earnings | (148.07 M) | ||||
| Working Capital | 83.96 M | ||||
| Net Asset | 101.71 M |
About LAVA Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LAVA Therapeutics NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LAVA Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LAVA Therapeutics NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LAVA Stock Analysis
When running LAVA Therapeutics' price analysis, check to measure LAVA Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LAVA Therapeutics is operating at the current time. Most of LAVA Therapeutics' value examination focuses on studying past and present price action to predict the probability of LAVA Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LAVA Therapeutics' price. Additionally, you may evaluate how the addition of LAVA Therapeutics to your portfolios can decrease your overall portfolio volatility.